Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles

KL Arienti, A Brunmark, FU Axe…

Index: Journal of Medicinal Chemistry, , vol. 48, # 6 p. 1873 - 1885

Full Text: HTML

Citation Number: 133

Abstract

... Journal of Medicinal Chemistry. ... Johnson & Johnson Pharmaceutical Research and Development, LLC, 3210 Merryfield Row, San Diego, California 92121. J. Med. Chem. , 2005, 48 (6), pp 1873–1885. DOI: 10.1021 ...

Checkpoint kinase inhibitors: SAR and radioprotective proper...

[Arienti, Kristen L.; Brunmark, Anders; Axe, Frank U.; McClure, Kelly; Lee, Alice; Blevitt, Jon; Neff, Danielle K.; Huang, Liming; Crawford, Shelby; Pandit, Chennagiri R.; Karlsson, Lars; Breitenbucher, J. Guy Journal of Medicinal Chemistry, 2005 , vol. 48, # 6 p. 1873 - 1885]

Resistance-modifying agents. 9. 1 synthesis and biological p...

[Journal of Medicinal Chemistry, , vol. 43, # 22 p. 4084 - 4097]

Process development for ABT-472, a benzimidazole PARP inhibi...

[Organic Process Research and Development, , vol. 11, # 4 p. 693 - 698]